CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 21,400 full-time employees. The firm operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The firm conducts its business in the domestic and overseas markets.
根據最新的財務報表(Form-10K),CSPC Pharmaceutical Group Limited 的總資產為 $0,淨損失為 $0
CSPCY 的關鍵財務比率是什麼?
CSPC Pharmaceutical Group Limited 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
CSPC Pharmaceutical Group Limited 的收入按細分市場或地理位置如何劃分?
CSPC Pharmaceutical Group Limited 最大收入來源為 Total Finished Drugs,在最近的收益報告中收入為 17,937,001,000。就地區而言,Mainland China 是 CSPC Pharmaceutical Group Limited 的主要市場,收入為 25,106,726,000。
CSPC Pharmaceutical Group Limited 是否盈利?
無,根據最新的財務報表,CSPC Pharmaceutical Group Limited 的淨損失為 $0